Glenmark Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 2,464.26 | 2,097.95 | 2,380.47 |
| Operating Expense | 1,990 | 1,848.13 | 1,757.35 |
| Net Profit | 330.23 | 147.76 | 413.80 |
| Net Profit Margin | 13.40 | 7.04 | 17.38 |
| Earning Per Share | 11.70 | 5.24 | 14.66 |
| EBIDTA | 473.50 | 190.80 | 572.68 |
| Effective Tax Rate | 14.80 | -10.26 | 15.29 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 2464.26 |
| Operating Expense | 1990.00 |
| Net Profit | 330.23 |
| Net Profit Margin | 13.40 |
| Earning Per Share | 11.70 |
| EBIDTA | 473.50 |
| Effective Tax Rate | 14.80 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 9,226.41 | 7,891.12 | 8,220.66 |
| Operating Expenses Annual | 6,982.23 | 6,649.46 | 6,747.90 |
| Operating Profit Annual | 2,421.38 | 7,480.02 | 1,962.84 |
| Interest Annual | 48.73 | 277.11 | 206.82 |
| Depreciation | 218.63 | 202.16 | 184.15 |
| Net Profit Annual | 1,610.35 | 5,167.29 | 1,208.77 |
| Tax Annual | 543.67 | 1,833.46 | 363.11 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 9,226.41 |
| Operating Expenses Annual | 6,982.23 |
| Operating Profit Annual | 2,421.38 |
| Interest Annual | 48.73 |
| Depreciation | 218.63 |
| Net Profit Annual | 1,610.35 |
| Tax Annual | 543.67 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 127.96 | 92.70 | 28.65 |
| Cash Flow from Operations | 588.80 | -495.45 | 1,474.06 |
| Cash Flow from Investing | -489.90 | 3,197.17 | -431.52 |
| Cash Flow from Financing | -95.41 | -2,666.45 | -978.50 |
| Cash Flow at the End | 131.45 | 127.96 | 92.70 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 127.96 |
| Cash Flow from Operations | 588.80 |
| Cash Flow from Investing | -489.90 |
| Cash Flow from Financing | -95.41 |
| Cash Flow at the End | 131.45 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 26.24 | 30.54 | 29.84 |
| PBIT Margin (%) | 23.87 | 27.98 | 27.60 |
| PBT Margin (%) | 23.38 | 27.88 | 27.47 |
| Net PROFIT Margin (%) | 17.45 | 65.48 | 14.70 |
| Return On Networth / Equity (%) | 6.78 | 6.98 | 9.12 |
| Return On Networth /Employed (%) | 8.94 | 9.75 | 10.79 |
| Return On Assets (%) | 6.46 | 22.92 | 5.73 |
| Total Debt / Equity (X) | 0.03 | 0.10 | 0.20 |
| Asset Turnover Ratio (%) | 0.37 | 0.35 | 0.39 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 26.24 |
| PBIT Margin (%) | 23.87 |
| PBT Margin (%) | 23.38 |
| Net PROFIT Margin (%) | 17.45 |
| Return On Networth / Equity (%) | 6.78 |
| Return On Networth /Employed (%) | 8.94 |
| Return On Assets (%) | 6.46 |
| Total Debt / Equity (X) | 0.03 |
| Asset Turnover Ratio (%) | 0.37 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 2,012.40 | 1,778.42 | 1,759.21 |
| Total Current Assets Annual | 4,777.67 | 4,681.47 | 4,386.48 |
| Non Current Assets Annual | 23,255.61 | 22,732.92 | 20,199.44 |
| Total Shareholders Funds Annual | 24,503.96 | 22,970.62 | 17,877.46 |
| Total Assets Annual | 28,033.28 | 27,414.39 | 24,585.92 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 2,012.40 |
| Total Current Assets Annual | 4,777.67 |
| Non Current Assets Annual | 23,255.61 |
| Total Shareholders Funds Annual | 24,503.96 |
| Total Assets Annual | 28,033.28 |
EPS (INR)
Expected
1.66
Reported
1.66
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
